Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants.

J. H. McAnulty, M. Morton, S. H. Rahimtoola, F. E. Kloster, N. Ahuja, Albert Starr

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards Model 2400 aortic track valve and Model 6400 mitral track valve) were evaluated in anticoagulated patients. The peak systolic gradient (mean +/- SE) for the aortic valve in 16 patients was 18.1 +/- 3.9 mm Hg; the mean gradient was 17.0 +/- 2.7 mm Hg; the prosthetic valve area was 1.7 +/- 0.1 cm2; and the valve area index was 1.0 +/- 0.1 cm2/m2. In the 19 patients with the mitral valve, the mean diastolic gradient (mean +/- SE) was 5.2 +/- 0.7 mm Hg. The prosthetic valve area was 2.0 +/- 0.1 cm2, and the valve area index was 1.3 +/- 0.1 cm2/m2. These hemodynamic parameters are helpful in evaluating the catheterization findings in patients with composite strut prosthetic valves who are suspected of having prosthesis dysfunction. They also demonstrate the satisfactory in vivo hemodynamics in anticoagulated patients with these prostheses.

Original languageEnglish (US)
JournalCirculation
Volume58
Issue number3 Pt 2
StatePublished - Sep 1978

Fingerprint

Anticoagulants
Prostheses and Implants
Hemodynamics
Aortic Valve
Mitral Valve
Catheterization

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

McAnulty, J. H., Morton, M., Rahimtoola, S. H., Kloster, F. E., Ahuja, N., & Starr, A. (1978). Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants. Circulation, 58(3 Pt 2).

Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants. / McAnulty, J. H.; Morton, M.; Rahimtoola, S. H.; Kloster, F. E.; Ahuja, N.; Starr, Albert.

In: Circulation, Vol. 58, No. 3 Pt 2, 09.1978.

Research output: Contribution to journalArticle

McAnulty, JH, Morton, M, Rahimtoola, SH, Kloster, FE, Ahuja, N & Starr, A 1978, 'Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants.', Circulation, vol. 58, no. 3 Pt 2.
McAnulty, J. H. ; Morton, M. ; Rahimtoola, S. H. ; Kloster, F. E. ; Ahuja, N. ; Starr, Albert. / Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants. In: Circulation. 1978 ; Vol. 58, No. 3 Pt 2.
@article{034cd7c538074f41a6f08dec8610c1ff,
title = "Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants.",
abstract = "The hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards Model 2400 aortic track valve and Model 6400 mitral track valve) were evaluated in anticoagulated patients. The peak systolic gradient (mean +/- SE) for the aortic valve in 16 patients was 18.1 +/- 3.9 mm Hg; the mean gradient was 17.0 +/- 2.7 mm Hg; the prosthetic valve area was 1.7 +/- 0.1 cm2; and the valve area index was 1.0 +/- 0.1 cm2/m2. In the 19 patients with the mitral valve, the mean diastolic gradient (mean +/- SE) was 5.2 +/- 0.7 mm Hg. The prosthetic valve area was 2.0 +/- 0.1 cm2, and the valve area index was 1.3 +/- 0.1 cm2/m2. These hemodynamic parameters are helpful in evaluating the catheterization findings in patients with composite strut prosthetic valves who are suspected of having prosthesis dysfunction. They also demonstrate the satisfactory in vivo hemodynamics in anticoagulated patients with these prostheses.",
author = "McAnulty, {J. H.} and M. Morton and Rahimtoola, {S. H.} and Kloster, {F. E.} and N. Ahuja and Albert Starr",
year = "1978",
month = "9",
language = "English (US)",
volume = "58",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3 Pt 2",

}

TY - JOUR

T1 - Hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards track valves) in patients on anticoagulants.

AU - McAnulty, J. H.

AU - Morton, M.

AU - Rahimtoola, S. H.

AU - Kloster, F. E.

AU - Ahuja, N.

AU - Starr, Albert

PY - 1978/9

Y1 - 1978/9

N2 - The hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards Model 2400 aortic track valve and Model 6400 mitral track valve) were evaluated in anticoagulated patients. The peak systolic gradient (mean +/- SE) for the aortic valve in 16 patients was 18.1 +/- 3.9 mm Hg; the mean gradient was 17.0 +/- 2.7 mm Hg; the prosthetic valve area was 1.7 +/- 0.1 cm2; and the valve area index was 1.0 +/- 0.1 cm2/m2. In the 19 patients with the mitral valve, the mean diastolic gradient (mean +/- SE) was 5.2 +/- 0.7 mm Hg. The prosthetic valve area was 2.0 +/- 0.1 cm2, and the valve area index was 1.3 +/- 0.1 cm2/m2. These hemodynamic parameters are helpful in evaluating the catheterization findings in patients with composite strut prosthetic valves who are suspected of having prosthesis dysfunction. They also demonstrate the satisfactory in vivo hemodynamics in anticoagulated patients with these prostheses.

AB - The hemodynamic characteristics of the composite strut ball valve prostheses (Starr-Edwards Model 2400 aortic track valve and Model 6400 mitral track valve) were evaluated in anticoagulated patients. The peak systolic gradient (mean +/- SE) for the aortic valve in 16 patients was 18.1 +/- 3.9 mm Hg; the mean gradient was 17.0 +/- 2.7 mm Hg; the prosthetic valve area was 1.7 +/- 0.1 cm2; and the valve area index was 1.0 +/- 0.1 cm2/m2. In the 19 patients with the mitral valve, the mean diastolic gradient (mean +/- SE) was 5.2 +/- 0.7 mm Hg. The prosthetic valve area was 2.0 +/- 0.1 cm2, and the valve area index was 1.3 +/- 0.1 cm2/m2. These hemodynamic parameters are helpful in evaluating the catheterization findings in patients with composite strut prosthetic valves who are suspected of having prosthesis dysfunction. They also demonstrate the satisfactory in vivo hemodynamics in anticoagulated patients with these prostheses.

UR - http://www.scopus.com/inward/record.url?scp=1342309994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1342309994&partnerID=8YFLogxK

M3 - Article

C2 - 14740696

AN - SCOPUS:1342309994

VL - 58

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3 Pt 2

ER -